Veklury Reduces Mortality in Immunocompromised People With COVID-19
The use of remdesivir (Veklury, Gilead) can have significant benefits for immunocompromised people with COVID-19, reducing mortality by 30%. Using the treatment promptly in these…
Thought Leader: Scott Gottlieb